Are Fetuin-A levels beneficial for estimating timing of sepsis occurrence?

References

1. ↵
   1. Pederson KO

   (1944) Fetuin, a New Globulin Isolated from Serum. Nature 154:575.

   OpenUrl
2. ↵
   1. Dziegielewska KM,
   2. Daikuhara Y,
   3. Ohnishi T,
   4. Waite MP,
   5. Ek J,
   6. Habgood MD,
   7. et al.

   (2000) Fetuin in the developing neocortex of the rat: distribution and origin. J Comp Neurol 423:373–388.

   OpenUrlCrossRefPubMedWeb of Science
3. 1. Kitchener PD,
   2. Dziegielewska KM,
   3. Hutton EJ,
   4. Hinrichsen CF,
   5. Saunders NR

   (1999) Fetuin in neurons of the retina and cerebellum during fetal and postnatal development of the rat. Int J Dev Neurosci 17:21–30.

   OpenUrlPubMed
4. ↵
   1. Terkelsen OB,
   2. Jahnen-Dechent W,
   3. Nielsen H,
   4. Moos T,
   5. Fink E,
   6. Nawratil P,
   7. et al.

   (1998) Rat fetuin: distribution of protein and mRNA in embryonic and neonatal rat tissues. Anat Embryol (Berl) 197:125–133.

   OpenUrlCrossRefPubMed
5. ↵
   1. Schafer C,
   2. Jahnen-Dechent W,
   3. Brandenburg V

   (2005) Klinische relevanz des. serumproteins fetuin-A. Einem regulator der kalzifizierung. Laborwelt 6:9–12, German.

   OpenUrl
6. ↵
   1. Schultze HE,
   2. Heide K,
   3. Haupt H

   (1962) Charakterisierung eines niedermolekularen A2-mukoids aus humanserum. Naturwissenschaften 49:15–17, German.

   OpenUrl
7. ↵
   1. Olivier E,
   2. Soury E,
   3. Ruminy P,
   4. Husson A,
   5. Parmentier F,
   6. Daveau M,
   7. et al.

   (2000) Fetuin-B, a second member of the fetuin family in mammals. Biochem J 350:589–597.

   OpenUrlAbstract/FREE Full Text
8. ↵
   1. Nie Z

   (1992) Fetuin: its enigmatic property of growth promotion. Am J Physiol 263:C551–C562.

   OpenUrlWeb of Science
9. ↵
   1. Wang H,
   2. Sama AE

   (2012) Anti-inflammatory role of fetuin-A in injury and infection. Curr Mol Med 12:625–633.

   OpenUrlCrossRefPubMed
10. ↵
    1. Kumbla L,
    2. Bhadra S,
    3. Subbiah MT

    (1991) Multifunctional role for fetuin (fetal protein) in lipid transport. FASEB J 5:2971–2975.

    OpenUrlPubMed
11. ↵
    1. Naito C,
    2. Hashimoto M,
    3. Watanabe K,
    4. Shirai R,
    5. Takahashi Y,
    6. Kojima M,
    7. et al.

    (2016) Facilitatory effects of fetuin-A on atherosclerosis. Atherosclerosis 246:344–351.

    OpenUrlCrossRefPubMed
12. ↵
    1. Sezer S,
    2. Uçar F,
    3. Ulusoy EK,
    4. Erdogan S,
    5. Bilen S,
    6. Züngün C,
    7. et al.

    (2014) Serum amyloid A, fetuin-A, and pentraxin-3 levels in patients with ischemic stroke: novel prognostic biomarkers? Turk J Med Sci 44:16–23.

    OpenUrl
13. ↵
    1. Li W,
    2. Zhu S,
    3. Li J,
    4. Huang Y,
    5. Zhou R,
    6. Fan X,
    7. et al.

    (2011) A hepatic protein, fetuin-A, occupies a protective role in lethal systemic inflammation. PLoS One 6:e16945.

    OpenUrlCrossRefPubMed
14. ↵
    1. Smith ER,
    2. Cai MM,
    3. McMahon LP,
    4. Pedagogos E,
    5. Toussaint ND,
    6. Brumby C,
    7. et al.

    (2013) Serum fetuin-A concentration and fetuin-A-containing calciprotein particles in patients with chronic inflammatory disease and renal failure. Nephrology (Carlton) 18:215–221.

    OpenUrlCrossRefPubMed
15. ↵
    1. Celebi G,
    2. Genc H,
    3. Gurel H,
    4. Sertoglu E,
    5. Kara M,
    6. Tapan S,
    7. et al.

    (2015) The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease. Saudi J Gastroenterol 21:139–145.

    OpenUrl
16. ↵
    1. Zissimopoulos A,
    2. Baloka L,
    3. Nagorni E,
    4. Karathanos E,
    5. Tsartsarakis A,
    6. Apostolidou V,
    7. et al.

    (2015) Serum levels of fetuin-A in patients with coronary artery disease. Corellation with SPET myocardium scintigraphy. Hell J Nucl Med 18:147.

    OpenUrl
17. ↵
    1. Dellinger RP,
    2. Levy MM,
    3. Rhodes A,
    4. Annane D,
    5. Gerlach H,
    6. Opal SM,
    7. et al.

    (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39:165–228.

    OpenUrlCrossRefPubMedWeb of Science
18. ↵
    1. Ohno-Machado L,
    2. Resnic FS,
    3. Matheny ME

    (2006) Prognosis in critical care. Annu Rev Biomed Eng 8:567–599.

    OpenUrlCrossRefPubMedWeb of Science
19. ↵
    1. Vincent JL

    (2006) Organ dysfunction in patients with severe sepsis. Surg Infect (Larchmt) 7:69–72.

    OpenUrlPubMed
20. ↵
    1. Ombrellino M,
    2. Wang H,
    3. Yang H,
    4. Zhang M,
    5. Vishnubhakat J,
    6. Frazier A,
    7. et al.

    (2001) Fetuin, a negative acute phase protein, attenuates TNF synthesis and the innate inflammatory response to carrageenan. Shock 15:181–185.

    OpenUrlCrossRefPubMedWeb of Science
21. ↵
    1. Gangneux C,
    2. Daveau M,
    3. Hiron M,
    4. Derambure C,
    5. Papaconstantinou J,
    6. Salier JP

    (2003) The inflammation-induced down-regulation of plasma Fetuin-A (alpha2HS-Glycoprotein) in liver results from the loss of interaction between long C/EBP isoforms at two neighboring binding sites. Nucleic Acids Res 31:5957–5970.

    OpenUrlCrossRefPubMedWeb of Science
22. ↵
    1. Gökmen F,
    2. Akbal A,
    3. Güneş F,
    4. Türkön H,
    5. Vural A,
    6. Binnetoğlu E,
    7. et al.

    (2015) Serum Fetuin-A level in patients with ankylosing spondylitis and its relationship with clinical parameters. Arch Rheumatol 30:1–5.

    OpenUrl
23. ↵
    1. Kusnierz-Cabala B,
    2. Gurda-Duda A,
    3. Panek J,
    4. Fedak D,
    5. Dumnicka P,
    6. Solnica B,
    7. et al.

    (2010) Serum fetuin A concentrations in patients with acute pancreatitis. Clin Lab 56:191–195.

    OpenUrlPubMed
24. 1. Metry G,
    2. Stenvinkel P,
    3. Qureshi AR,
    4. Carrero JJ,
    5. Yilmaz MI,
    6. Barany P,
    7. et al.

    (2008) Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent hemodialysis patients. Eur J Clin Invest 38:804–811.

    OpenUrlCrossRefPubMedWeb of Science
25. ↵
    1. Sato H,
    2. Kazama JJ,
    3. Wada Y,
    4. Kuroda T,
    5. Narita I,
    6. Gejyo F,
    7. et al.

    (2007) Decreased levels of circulating alpha2-Heremans-Schmid glycoprotein/Fetuin-A (AHSG) in patients with rheumatoid arthritis. Intern Med 46:1685–1691.

    OpenUrlCrossRefPubMedWeb of Science
26. ↵
    1. Sadik NA,
    2. Mohamed WA,
    3. Ahmed MI

    (2012) The association of receptor of advanced glycated end products and inflammatory mediators contributes to endothelial dysfunction in a prospective study of acute kidney injury patients with sepsis. Mol Cell Biochem 359:73–81.

    OpenUrlCrossRefPubMed
27. ↵
    1. Weikert C,
    2. Stefan N,
    3. Schulze MB,
    4. Pischon T,
    5. Berger K,
    6. Joost HG,
    7. et al.

    (2008) Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 118:2555–2562.

    OpenUrlAbstract/FREE Full Text
28. ↵
    1. Dziegielewska KM,
    2. Brown WM,
    3. Gould CC,
    4. Matthews N,
    5. Sedgwick JE,
    6. Saunders NR

    (1992) Fetuin: an acute phase protein in cattle. J Comp Physiol 162:168–171.

    OpenUrl
29. ↵
    1. Tuttolomondo A,
    2. Di Raimondo D,
    3. Di Sciacca R,
    4. Casuccio A,
    5. Bivona G,
    6. Bellia C,
    7. et al.

    (2010) Fetuin-A and CD40 L plasma levels in acute ischemic stroke: differences in relation to TOAST subtype and correlation with clinical and laboratory variables. Atherosclerosis 208:290–296.

    OpenUrl